Vivanza Biosciences share news, announcements and annual reports
BSE: 530057Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹1.43.
30 Oct: open ₹1.50, high ₹1.60, low ₹1.50
- Next results date: the board meets on 3 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6.16 Cr4,790th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 13.57
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.41
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 10.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 2.34
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 24,333
Vivanza Biosciences share news and announcements
594 announcements, routine notices left out, newest first. Page 5 of 12.
Apr 2023
24 Apr · Compliance Under Regulation 40 (9) For The Financial Year Ended On 31St March, 2023
6 Apr · Compliances-Compliance Certificate For The Financial Year Ended March, 2023
Mar 2023
29 Mar · Announcement under Regulation 30 (LODR)-Meeting Updates
28 Mar · Board meeting
Meeting on 25 Apr 2023: audited results6 Mar · Board meeting
Meeting on 4 Mar 2023: stock split
Feb 2023
20 Feb · Details Of Web Link Under Regulation 46 And 62 Of The SEBI (LODR) Regulations, 2015. Ref: BSE Notice No. 20230209-1 Dated 9Th February, 2023- Release Of New Module For Filing Of Information Required Under Regulation 46 And 62 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 On BSE Listing Center
20 Feb · Copy Of Email And/Or SMS Sent To Shareholders Holding Physical Shares As Directed By SEBI Vide Circular No. SEBI/HO/OIAE/2023/03391 Dated January 27, 2023.
Jan 2023
12 Jan · Board meeting
Meeting on 24 Jan 2023: stock split and quarterly results
Dec 2022
22 Dec · Legal
Exchange has sought clarification from Vivanza Biosciences Ltd on December 21, 2022 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Nov 2022
15 Nov · Non Applicability Of Regulation 23(9) Of SEBI (LODR) Regulations, 2015 For The Quarter And Half Year Ended On September 30, 2022
7 Nov · Board meeting
Meeting on 11 Nov 2022: quarterly results
Oct 2022
6 Oct · Statement Of Investor Complaints For The Quarter Ended September 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 15 15 <td class='TTRow'
Aug 2022
30 Aug · Non-Applicability Of Disclosure Of Related Party Transaction On Consolidated Basis.
Jul 2022
23 Jul · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly <a href="https://www.bseindia.com/stock-share-price/meetings/voting-results/530057 ....22 Jul · Meeting
21 Jul · Board meeting
13 Jul · Board meeting
Meeting on 21 Jul 2022: quarterly results12 Jul · Statement Of Investor Complaints For The Quarter Ended June 2022
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Jun 2022
29 Jun · Reg. 34 (1) Annual Report.
17 Jun · Board meeting
Meeting on 21 Jun 2022: preferential issue of shares13 Jun · Board meeting
Meeting on 15 Jun 2022: annual general meeting
May 2022
27 May · Board meeting
18 May · Board meeting
Meeting on 27 May 2022: audited results, quarterly results, preferential issue of shares and annual general meeting
Apr 2022
30 Apr · Compliance Certificate By PCS For Half Year Ended 31/03/2022
29 Apr · Compliance Certificate Under Reg. 7(3) For Period Of 1St April, 2021 To 31St March, 2022